Centre Barbelé - Strassen / Luxembourg


ADHS a.s.b.l.

Elements recommended for inclusion in Summaries of Product Characteristics for methylphenidate-containing medicinal products authorised for the treatment of ADHD in children aged six years and above and adolescents

Wording recommended by the CHMP on 22 January 2009. This recommendation will be sent to the European Commission for the adoption of a decision applicable in all EU Member States.

<<< LINK